Researchers at the Institute of Clinical Chemistry and Pathobiochemistry (IKCP) of the Medical Faculty of the Otto von Guericke University Magdeburg report a potential new approach to treat diabetic nephropathy in the Journal of American Society of Nephrology (JASN), the leading journal in the field.
Diabetic nephropathy is a progressive diabetic kidney disease and contributes to more than 40 % of newly diagnosed end-stage renal disease cases. Diabetic nephropathy is associated with high socio-economic costs and is considered the leading cause of morbidity and mortality in diabetic patients. However, once the disease is established, current therapies can not reverse or even stop the progression of the disease. At best, current therapies slow the progression of the disease. Hence, new treatment options are urgently needed.